(Q46646250)

23 December 2017

title

Management of hepatitis C-infected liver transplant recipients at large North American centres: changes in recent years (English)

1 reference

23 December 2017

6

John P Roberts

1 reference

23 December 2017

Norah A Terrault

7

object named as

Norah A Terrault

1 reference

23 December 2017

author name string

Mandana Khalili

1

1 reference

23 December 2017

Andrew J Vardanian

2

1 reference

23 December 2017

Chris M Hamerski

3

1 reference

23 December 2017

Rou Wang

4

1 reference

23 December 2017

Peter Bacchetti

5

1 reference

23 December 2017

publication date

1 January 2006

1 reference

23 December 2017

published in

Clinical Transplantation

1 reference

23 December 2017

volume

20

1 reference

23 December 2017

issue

1

1 reference

23 December 2017

page(s)

1-9

1 reference

23 December 2017

The association between hepatitis C infection and survival after orthotopic liver transplantation

cites work

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Impact of the recurrence of hepatitis C virus infection after liver transplantation on the long-term viability of the graft

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

High incidence of allograft cirrhosis in hepatitis C virus genotype 1b infection following transplantation: relationship with rejection episodes.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Long-term outcome of hepatitis C infection after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

European collaborative study on factors influencing outcome after liver transplantation for hepatitis C. European Concerted Action on Viral Hepatitis (EUROHEP) Group.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Fibrosis progression after liver transplantation in patients with recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Natural history of clinically compensated hepatitis C virus-related graft cirrhosis after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Factors that identify survival after liver retransplantation for allograft failure caused by recurrent hepatitis C infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Poor survival after liver retransplantation: is hepatitis C to blame?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Report of the first International Liver Transplantation Society expert panel consensus conference on liver transplantation and hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Anti-interleukin-2 receptor therapy in combination with mycophenolate mofetil is associated with more severe hepatitis C recurrence after liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Improved treatment response with basiliximab immunoprophylaxis after liver transplantation: results from a double-blind randomized placebo-controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Ribavirin dose modification based on renal function is necessary to reduce hemolysis in liver transplant patients with hepatitis C virus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Treatment of posttransplantation recurrence of hepatitis C with interferon and ribavirin: lessons on tolerability and efficacy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

A pilot study of interferon alfa and ribavirin combination in liver transplant recipients with recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

The past incidence of hepatitis C virus infection: implications for the future burden of chronic liver disease in the United States

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Liver transplantation for hepatocellular cancer: the impact of the MELD allocation policy

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Are posttransplantation protocol liver biopsies useful in the long term?

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Comparison of tacrolimus with microemulsion cyclosporine as primary immunosuppression in hepatitis C patients after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Orthotopic liver transplantation for hepatitis C: outcome, effect of immunosuppression, and causes of retransplantation during an 8-year single-center experience

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

A randomized double-blind comparative study of mycophenolate mofetil and azathioprine in combination with cyclosporine and corticosteroids in primary liver transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Steroid-free liver transplantation using rabbit antithymocyte globulin and early tacrolimus monotherapy1

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Slowly tapering off steroids protects the graft against hepatitis C recurrence after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Tapering off steroids three months after liver transplantation is not detrimental for hepatitis C virus disease recurrence

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Severe or multiple rejection episodes are associated with early recurrence of hepatitis C after orthotopic liver transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Combination of interferon alfa-2b and ribavirin in liver transplant recipients with histological recurrent hepatitis C.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Interferon-alpha 2b plus ribavirin in patients with chronic hepatitis C after liver transplantation: a randomized study.

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Effects of interferon treatment on liver histology and allograft rejection in patients with recurrent hepatitis C following liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Ribavirin/interferon-alpha sequential treatment of recurrent hepatitis C after liver transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Hepatitis C infection in patients undergoing liver retransplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Retransplantation of liver: primary graft nonfunction and hepatitis C virus are associated with worse outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Long-term survival after retransplantation of the liver

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

Hepatic Retransplantation--an analysis of risk factors associated with outcome

21 January 2018

1 reference

https://api.crossref.org/works/10.1111%2FJ.1399-0012.2005.00449.X

10.1111/J.1399-0012.2005.00449.X

21 January 2018

Identifiers

DOI

1 reference

23 December 2017

1 reference

23 December 2017